Literature DB >> 17670435

Mitral annuloplasty with biodegradable ring for infective endocarditis: a new tool for the surgeon for valve repair in childhood.

Hakki Kazaz1, Mehmet Adnan Celkan, Hasim Ustunsoy, Osman Baspinar.   

Abstract

The incidence of bacterial endocarditis and valvular involvement is rare in the childhood period. If the patient is unresponsive to medical treatment and some complications occur, early surgical treatment is indicated. Debridement of vegetation combined with valve repair techniques sparing the native valve is the ideal surgical procedure instead of replacement, especially for children. Annuloplasty is the key step during valve repair procedures. On the other hand, absence of appropriate sized annuloplasty rings on the market for this group of patients is the main problem. Nondegradable annuloplasty rings might lead to stenosis as the child grows. Thus, biodegradable tissue engineered materials are new solutions for such patients since the fibrous tissue induced by implanted ring grows with time. We describe a pediatric patient with Brucella endocarditis at the mitral position who was treated successfully with valve repair using a biodegradable annuloplasty ring (Kalangos Biodegradable Ring).

Entities:  

Year:  2005        PMID: 17670435     DOI: 10.1510/icvts.2005.105833

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  3 in total

1.  Clinical and echocardiographic results of the Kalangos biodegradable tricuspid ring for moderate and severe functional tricuspid regurgitation treatment.

Authors:  Tugrul Goncu; Ihsan Alur; Arif Gucu; Erhan Tenekecioglu; Faruk Toktas; Nail Kahraman; Hakan Vural; Senol Yavuz
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Valve repair using biodegradable ring annuloplasty: from bench to long-term clinical results.

Authors:  P O Myers; A Kalangos
Journal:  Heart Lung Vessel       Date:  2013

Review 3.  Biodegradable materials for surgical management of infective endocarditis: new solution or a dead end street?

Authors:  Patrick O Myers; Mustafa Cikirikcioglu; Afksendiyos Kalangos
Journal:  BMC Surg       Date:  2014-08-03       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.